Blockchain Registration Transaction Record

Humabiologics Launches Affordable Human Collagen for Research

Humabiologics introduces research-grade human collagen to aid life sciences researchers facing funding challenges. The product offers superior clinical relevance for regenerative medicine and organ-on-a-chip applications. This launch follows a recent grant to advance human collagen biomanufacturing.

This news matters as it addresses the critical funding issues researchers face due to budget constraints, offering a solution that accelerates translation of research into clinical solutions. By providing ethically sourced biomaterials at an affordable price, Humabiologics removes cost barriers and enables scientists to work with more clinically relevant models, driving advancements in regenerative therapies and tissue engineering.